KENYON DRAPER: Open Payments
NPI 1144573197 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 30 payments from 12 companies in 2025. Trend: 2023 $672 · 2024 $582 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $103 |
| Lilly USA, LLC | 4 | $90 |
| ABBVIE INC. | 5 | $83 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 4 | $35 |
| Dynavax Technologies Corporation | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
Products named: MOUNJARO, Ozempic, VRAYLAR, Wegovy, VOQUEZNA, LINZESS, Heplisav-B, XIFAXAN.
Industry payments across NC — which companies pay providers there.
